Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794274 · ClinicalTrials.gov registry record · Phase 2
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
A Phase 2 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00794274 is a Phase 2 study that has completed, run by University of Cincinnati. The registered enrollment target is 15 participants.
The verdict
NCT00794274, a Phase 2 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
To determine whether CC-10004, a phosphodiesterase inhibitor, is useful in treating chronic cutaneous sarcoidosis.
Interventions
- DRUG CC-100004
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00794274
The ClinicalTrials.gov registry entry for NCT00794274 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CC-100004 is the first listed.
NCT00794274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00794274 about?
NCT00794274 is a clinical study titled "The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis". To determine whether CC-10004, a phosphodiesterase inhibitor, is useful in treating chronic cutaneous sarcoidosis.
What is the current status of trial NCT00794274?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2008-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00794274?
The interventions under investigation include: CC-100004 (DRUG).
Who is sponsoring clinical trial NCT00794274?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.